L'anakinra est une alternative possible dans le traitement et la prévention des crises de pseudogoutte au stade terminal d'une insuffisance rénale

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Revue du Rhumatisme

• Publication date

  2009-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.RHUM.2009.01.009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treating difficult crystal pyrophosphate dihydrate deposition disease

  2008cited by this paper
• Successful treatment of resistant pseudogout with anakinra.

  2008cited by this paper
• Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al.

  2008cited by this paper
• Update in calcium deposition diseases

  2007cited by this paper
• A pilot study of IL-1 inhibition by anakinra in acute gout

  2007cited by this paper
• Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.

  2007cited by this paper
• The inflammasome, autoinflammatory diseases, and gout.

  2007cited by this paper
• Colchicine prescribing and safety monitoring in patients with gout.

  2007cited by this paper
• Is IL-1 a good therapeutic target in the treatment of arthritis?

  2006cited by this paper
• The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.

  2006cited by this paper
• TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation1

  2005cited by this paper
• Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.

  2005cited by this paper
• The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

  2002cited by this paper
• Molecular and cellular effects of methotrexate.

  1999cited by this paper
• Interleukin-1 receptor antagonist: role in biology.

  1998cited by this paper
• Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

  1988cited by this paper

• No citing papers are available for this paper.